The assessment of treatment outcomes in metastatic prostate cancer: Changing endpoints

被引：23

作者：

Dawson, NA

McLeod, DG

机构：

[1] WALTER REED ARMY MED CTR,UROL SERV,WASHINGTON,DC 20307

[2] UNIFORMED SERV UNIV HLTH SCI,BETHESDA,MD 20814

来源：

EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷 / 04期

关键词：

D O I：

10.1016/S0959-8049(96)00443-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：560 / 565

页数：6

共 52 条

[1]

Aaronson N K, 1988, Recent Results Cancer Res, V111, P231

[2]

AHMANN FR, 1990, P AN M AM SOC CLIN, V9, P134

[3]

[Anonymous], 1958, 1 10 YEARS WORLD HLT

[4]

[Anonymous], P AM SOC CLIN ONCOL

[5] PROGNOSTIC-SIGNIFICANCE OF PROSTATE SPECIFIC ANTIGEN IN ENDOCRINE TREATMENT FOR PROSTATIC-CANCER [J].

ARAI, Y ;

YOSHIKI, T ;

YOSHIDA, O .

JOURNAL OF UROLOGY, 1990, 144 (06) :1415-1419

[6]

BLACKARD CE, 1975, CANCER CHEMOTH REP 1, V59, P225

[7]

Cassileth B R, 1992, Qual Life Res, V1, P323, DOI 10.1007/BF00434946

[8]

CASSILETH BR, 1991, CONTROVERSIES MANA 6

[9] THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].

CELLA, DF ;

TULSKY, DS ;

GRAY, G ;

SARAFIAN, B ;

LINN, E ;

BONOMI, A ;

SILBERMAN, M ;

YELLEN, SB ;

WINICOUR, P ;

BRANNON, J ;

ECKBERG, K ;

LLOYD, S ;

PURL, S ;

BLENDOWSKI, C ;

GOODMAN, M ;

BARNICLE, M ;

STEWART, I ;

MCHALE, M ;

BONOMI, P ;

KAPLAN, E ;

TAYLOR, S ;

THOMAS, CR ;

HARRIS, J .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579

[10]

CITRIN DL, 1974, LANCET, V1, P1132

← 1 2 3 4 5 6 →